Published: March 10, 2023
Last updated: September 27, 2026
Next review: September 2027, or sooner if major hypertrophic cardiomyopathy guidance changes
Written and source - checked by: Adel Galal, Founder and Lead Writer at NextFitLife
Hypertrophic cardiomyopathy, usually shortened to HCM, causes part of the heart muscle to become abnormally thick. Some people never develop major symptoms, while others experience breathlessness, chest discomfort, palpitations, dizziness, fainting, or reduced exercise ability.
The old advice for HCM was often overly restrictive: avoid exercise, avoid exertion, and live cautiously.
Modern care is more personal.
The 2024 American Heart Association and American College of Cardiology guideline encourages mild to moderate recreational exercise for most people with HCM, uses individual risk assessment rather than automatically implanting defibrillators, places greater emphasis on family screening, and includes cardiac myosin inhibitors among treatment options for symptomatic obstructive disease.
There has been another important change since that guideline was written. In December 2025, the U.S. Food and Drug Administration approved aficamten for adults with symptomatic obstructive HCM. Along with mavacamten, this gives specialists another disease specific treatment option for selected patients.
Get Emergency Help for These Symptoms
Seek emergency medical care for fainting during exertion, severe chest pain or pressure, severe or rapidly worsening shortness of breath, collapse, loss of consciousness, or a sustained very fast or irregular heartbeat with serious symptoms.
If someone becomes unresponsive and is not breathing normally, contact your local emergency service and begin CPR if you are trained or follow dispatcher instructions.
I am not a dermatologist or A doctor, and this content does not replace professional medical advice. What I share comes from real-life experience, extensive research, and consultation with healthcare providers. Always consult qualified medical professionals for diagnosis and treatment of any health condition.
Quick Answer: How Do You Live Well With Hypertrophic Cardiomyopathy?
Living well with hypertrophic cardiomyopathy starts with knowing whether your HCM is obstructive, staying active at an appropriate level, avoiding dehydration, tracking changing symptoms, controlling other heart risks, assessing sudden cardiac death risk, and keeping family screening up to date.
Treatment can include beta blockers, certain calcium channel blockers, cardiac myosin inhibitors, rhythm treatment, an implantable defibrillator for selected high risk patients, or septal reduction procedures when obstruction continues to cause serious symptoms.
The right plan is individual. HCM affects people differently, which is why major exercise, medicine, sports, pregnancy, and procedure decisions should be made with a cardiology team experienced in HCM.
For the wider cardiovascular picture, visit the NextFitLife Heart and Cardiovascular Health Guide.
Table of Contents
- What hypertrophic cardiomyopathy means
- Obstructive versus nonobstructive HCM
- Common symptoms
- 1. Build care around an HCM specialist
- 2. Know your HCM type and test results
- 3. Exercise instead of automatically avoiding activity
- 4. Protect hydration and avoid heat stress
- 5. Build a heart healthy daily routine
- 6. Monitor symptoms and heart rhythm
- 7. Understand modern HCM treatment
- 8. Know your sudden cardiac death risk
- 9. Screen close family members
- 10. Plan for sports, pregnancy, travel, and other situations
- Questions to ask your cardiologist
- Emergency warning signs
- References and Sources
- Continue Reading on NextFitLife
- About the Author
- Frequently Asked Questions
What Is Hypertrophic Cardiomyopathy?
Hypertrophic cardiomyopathy is a disease in which heart muscle becomes abnormally thick.
The thickening often affects the wall between the two lower chambers of the heart, called the septum, but other parts of the left ventricle can also be involved.
HCM is commonly genetic.
Changes in genes that control heart muscle proteins can run through families. This is why a diagnosis in one person can have implications for parents, siblings, children, and other close relatives.
Still, a thick heart muscle is not automatically HCM.
Long standing high blood pressure, valve disease, athletic remodeling, amyloidosis, Fabry disease, and other conditions can also cause heart thickening.
A proper diagnosis therefore asks two questions:
- Is this truly hypertrophic cardiomyopathy?
- If it is HCM, what type and risk profile does this person have?
Obstructive and Nonobstructive HCM Are Different
HCM is often divided into obstructive HCM and nonobstructive HCM.
| Type | What Happens? | Why It Matters? |
|---|---|---|
| Obstructive HCM | Thickened heart structures interfere with blood leaving the left ventricle | Hydration, medicines, exercise advice, and treatment of obstruction become especially important |
| Nonobstructive HCM | Heart muscle is thickened without a major left ventricular outflow obstruction | Symptoms can still come from stiff filling, rhythm problems, reduced exercise reserve, or heart failure |
The distinction is not always obvious from a resting test.
Some people have little obstruction at rest but develop a significant gradient during standing, straining, or exercise.
The 2024 guideline therefore recommends provocative maneuvers when the resting gradient is not clearly obstructive and exercise echocardiography in selected patients when obstruction remains uncertain.
What Symptoms Can HCM Cause?
Some people have no symptoms and discover HCM through family screening or an unexpected ECG or echocardiogram result.
Others develop:
- Shortness of breath during activity
- Chest discomfort or pressure
- Palpitations
- Dizziness
- Lightheadedness
- Fainting or near fainting
- Fatigue
- Reduced exercise ability
- Swelling if heart failure develops
Symptoms can change from day to day.
Dehydration, heat, a large meal, alcohol, illness, poor sleep, changes in heart rhythm, and medication effects can all change how someone with HCM feels.
A new symptom pattern deserves attention because HCM itself can change over time.
1. Build Your Care Around the Right HCM Expertise
Routine cardiology care can handle many parts of HCM management.
Complex decisions are different.
The current AHA and ACC guideline encourages involvement of a multidisciplinary HCM center for decisions involving difficult diagnosis, genetic counseling, invasive treatment, complex exercise questions, sudden death risk, and advanced therapy.
An experienced HCM team may include:
- Cardiologists familiar with HCM
- Cardiac imaging specialists
- Electrophysiologists
- Genetic counselors
- Heart surgeons
- Sports cardiology specialists
- Heart failure specialists
You do not need every specialist at every visit.
You do want access to the right expertise when a major decision appears.
2. Know Your HCM Type and the Tests That Matter
“I have HCM” is only the beginning of the useful information.
Ask your cardiology team about:
- Where the heart muscle is thickened
- Your maximum wall thickness
- Whether you have left ventricular outflow tract obstruction
- Your resting and provoked gradient when relevant
- Your ejection fraction
- Whether a cardiac MRI shows scar or an apical aneurysm
- Whether rhythm monitoring found nonsustained ventricular tachycardia
- Whether atrial fibrillation is present
Echocardiogram
A transthoracic echocardiogram is central to diagnosis and follow up.
The 2024 guideline recommends repeating echocardiography about every one to two years in people with established HCM, or sooner when clinical status changes.
Cardiac MRI
Cardiac MRI can help when echocardiography does not provide enough information.
It can also identify scar, show apical disease more clearly, help distinguish HCM from other causes of heart thickening, and support sudden death risk assessment.
Exercise Testing
Exercise testing can reveal symptoms, functional limitations, blood pressure behavior, rhythm issues, and obstruction that does not appear at rest.
For more on cardiovascular testing, see the Medical Tests and Screenings Guide.
3. Exercise Is Usually Part of HCM Care, Not Something to Fear
This is one of the biggest changes from older HCM advice.
The 2024 guideline states that mild to moderate recreational exercise is beneficial for most people with HCM because it can support fitness, physical function, quality of life, and general cardiovascular health.
A blanket ban on exercise is no longer the default.
Walking, cycling, recreational swimming, and other suitable aerobic activities may fit an individualized plan.
The exact activity should reflect symptoms, obstruction, rhythm history, blood pressure response, prior fainting, medications, and sudden death risk.
What About Vigorous Exercise?
The modern answer is more nuanced than “never.”
The guideline says vigorous recreational exercise can be reasonable for selected patients after comprehensive evaluation and shared decision making with an HCM expert.
Competitive sport may also be possible for some people after specialist assessment.
This does not mean every person with HCM should begin intense training.
It means universal restriction is no longer supported.
Stop exercise and seek medical advice if activity causes unexplained fainting, chest pain, severe breathlessness, or a sustained rapid or irregular heartbeat.
If your cardiologist has cleared you for exercise, you can also review Exercises for Cholesterol and Heart Health for general cardiovascular activity ideas.
4. Protect Hydration and Respect Heat
Dehydration can matter more in HCM than many generic heart health articles explain.
When blood volume falls, obstruction can become worse in some people with obstructive HCM.
The 2024 guideline specifically advises avoiding dehydration and extreme environmental conditions such as excessive heat and humidity, especially when obstructive physiology is present.
Practical habits can include:
- Drink regularly according to your medical plan
- Plan ahead for hot weather
- Avoid becoming severely dehydrated during exercise
- Replace fluid after heavy sweating when medically appropriate
- Be careful with saunas and very hot environments
- Ask how diuretics or fluid restrictions change your personal hydration plan
More water is not automatically better.
If you also have heart failure, kidney disease, or a prescribed fluid restriction, your clinician may give you very different instructions.
5. Build a Heart Healthy Daily Routine Around HCM
No special diet can remove a genetic HCM mutation or reverse established hypertrophy.
A heart healthy eating pattern still matters because high blood pressure, obesity, diabetes, cholesterol problems, and smoking add cardiovascular stress on top of HCM.
Build Meals Around Simple Foods
A practical pattern can include:
- Vegetables
- Fruit
- Whole grains
- Beans and lentils
- Fish
- Suitable lean protein
- Nuts and seeds
- Unsaturated oils
Limit heavy dependence on highly processed food, excess sodium, added sugar, and foods rich in saturated fat.
If you have heart failure or kidney disease as well, sodium, fluid, and potassium advice needs to match your medical plan.
Maintain a Healthy Weight
The HCM guideline recommends comprehensive lifestyle treatment for people with overweight or obesity.
Excess weight can add breathing difficulty, high blood pressure, metabolic disease, sleep apnea, and additional workload on the heart.
Do Not Smoke
Smoking and nicotine increase cardiovascular risk even though they are not the genetic cause of HCM.
Manage Blood Pressure Carefully
High blood pressure can worsen heart thickening and overall cardiovascular risk.
Medication selection can require extra care in obstructive HCM because some medicines that lower vascular resistance or fluid volume can worsen obstruction in selected patients.
Do not change blood pressure treatment without the clinician managing your HCM.
For broader prevention guidance, visit Heart Health 101 and How to Lower Blood Pressure Safely.
6. Track Symptoms and Heart Rhythm Instead of Guessing
A symptom diary can be surprisingly useful.
Record changes such as:
- New breathlessness
- Chest discomfort
- Palpitations
- Dizziness
- Fainting or near fainting
- Declining exercise capacity
- New swelling
Add the situation around the symptom.
Were you exercising?
Had you been in hot weather?
Were you dehydrated?
Did the episode begin after a large meal?
Did your wearable record an irregular rhythm?
This can help the cardiology team decide whether rhythm monitoring, exercise testing, imaging, or medication review is appropriate.
Atrial Fibrillation Matters More in HCM
Atrial fibrillation can be poorly tolerated in HCM because the stiff ventricle depends on coordinated filling.
The 2024 guideline takes stroke prevention in HCM related AF seriously and recommends anticoagulation for clinical atrial fibrillation regardless of the usual CHA2DS2 VASc score.
This is a prescription decision.
Do not start aspirin or an anticoagulant on your own.
If palpitations are a recurring problem, read Heart Failure Symptoms for related cardiac warning signs and discuss rhythm monitoring with your clinician.
7. Understand How Modern HCM Treatment Has Changed
Treatment depends heavily on whether HCM is obstructive, how severe symptoms are, and whether rhythm or heart failure complications are present.
Beta Blockers
For symptomatic obstructive HCM, the 2024 guideline recommends a non vasodilating beta blocker as first line therapy.
These medicines can slow the heart and give it more time to fill.
Verapamil or Diltiazem
If a beta blocker is not tolerated or does not work well enough, a nondihydropyridine calcium channel blocker such as verapamil or diltiazem may be considered in suitable patients.
These drugs are not appropriate for every obstructive HCM pattern.
Cardiac Myosin Inhibitors
This treatment area has changed quickly.
Mavacamten became the first FDA approved cardiac myosin inhibitor for adults with symptomatic obstructive HCM in 2022.
In December 2025, the FDA approved aficamten for adults with symptomatic obstructive HCM to improve functional capacity and symptoms.
These medicines reduce excessive heart muscle contraction.
They can also reduce heart pumping strength too much, which is why structured echocardiographic monitoring and careful medication interaction review are required.
2026 update: Aficamten also produced positive results in the ACACIA HCM trial for symptomatic nonobstructive HCM. As of September 2026, however, there is still no FDA approved myosin inhibitor indication for symptomatic nonobstructive HCM. Positive trial results do not equal an approved indication.
Septal Reduction Therapy
If severe symptoms remain because of important outflow obstruction despite appropriate medical treatment, specialists may consider septal myectomy or alcohol septal ablation.
The guideline recommends that septal reduction procedures be performed at experienced HCM centers.
Surgery can be especially appropriate when another heart problem, such as important mitral valve disease, also needs surgical treatment.
8. Know Your Sudden Cardiac Death Risk Without Living in Fear
Sudden cardiac death gets a great deal of attention in discussions about HCM.
The risk is real.
It is not the same for every person.
The current guideline recommends formal sudden death risk reassessment every one to two years in adolescents and adults with HCM.
Important risk markers include:
- Previous cardiac arrest or sustained ventricular arrhythmia
- Sudden death related to HCM in a close relative at a young age
- Marked heart muscle thickening
- Recent fainting suspected to be caused by an arrhythmia
- An apical aneurysm with scar
- Reduced left ventricular systolic function
- Important ventricular arrhythmias found on monitoring
- Cardiac MRI scar information in selected decisions
This assessment helps determine whether an implantable cardioverter defibrillator, or ICD, should be considered.
An ICD is clearly recommended for people with HCM who have survived cardiac arrest or sustained ventricular tachycardia.
Primary prevention decisions are more individual.
An ICD should not be implanted simply because someone wants permission to play sport.
9. Family Screening Is Part of HCM Care
This is not just your diagnosis.
HCM commonly runs in families, so first degree relatives need to know that screening may apply to them.
First degree relatives include:
- Parents
- Brothers and sisters
- Children
The 2024 guideline recommends offering clinical screening with an ECG and echocardiogram to first degree relatives.
When a pathogenic or likely pathogenic genetic variant is identified in the affected family member, cascade genetic testing can help identify relatives who inherited that variant.
How Often Is Family Screening Repeated?
| Family Member | Typical Clinical Follow Up |
|---|---|
| Children and adolescents in genotype positive or early onset families | Often every 1 to 2 years |
| Other children and adolescents | Often every 2 to 3 years, adjusted for family history and clinical circumstances |
| Adults at risk | Often every 3 to 5 years, or sooner if symptoms appear |
Screening intervals can change when symptoms develop or when a family has early or severe disease.
Genetic counseling helps families understand what a test result can and cannot tell them.
10. Plan Ahead for Sports, Pregnancy, Sleep, Travel, and Daily Life
HCM follows you into ordinary life decisions, but that does not mean life must become small.
Sports
The modern approach uses shared decision making.
Competitive or vigorous activity may be possible for some people after specialist assessment rather than automatic exclusion.
Pregnancy
Many women with clinically stable HCM can have successful pregnancies, but pregnancy increases cardiovascular demands and should be planned with cardiology and obstetric care.
Women taking beta blockers require appropriate monitoring.
Mavacamten is contraindicated in pregnancy because of fetal risk, and any cardiac myosin inhibitor requires careful pregnancy planning with the prescribing team.
Sleep
Sleep disordered breathing can worsen cardiovascular stress.
The HCM guideline recommends assessment for sleep disordered breathing symptoms and referral for evaluation when they are present.
Watch for loud snoring, witnessed breathing pauses, gasping, morning headache, or marked daytime sleepiness.
Read Sleep and Heart Health for more detail.
Travel
Keep medicines accessible, stay within your personal hydration plan, know where emergency help is available, and avoid allowing travel schedules to interrupt prescribed medicine or monitoring.
If you have an ICD, discuss device documentation and travel questions with your device clinic.
Dental and Routine Medical Care
Make sure other healthcare professionals know about your HCM and medicines.
This matters when prescribing decongestants, stimulants, blood pressure medicines, anesthesia, or medicines that interact with a cardiac myosin inhibitor.
Is There a Special Hypertrophic Cardiomyopathy Diet?
No diet has been shown to remove HCM or reverse a disease causing genetic variant.
A heart healthy eating pattern is still useful because it helps control the cardiovascular problems that can sit on top of HCM.
| Focus | Practical Approach |
|---|---|
| Vegetables and fruit | Use them regularly across meals and snacks |
| Whole grains | Choose oats, barley, brown rice, or whole grain products more often |
| Protein | Use fish, beans, lentils, poultry, nuts, seeds, and suitable dairy or alternatives |
| Fats | Favor unsaturated fat sources such as olive oil and nuts over foods high in saturated fat |
| Sodium | Avoid excessive intake and follow a specific restriction only when your care plan requires it |
Large meals can worsen symptoms in some people with obstructive HCM because blood flow shifts toward digestion and filling conditions change.
If you notice a consistent pattern after enormous meals, discuss it with your HCM clinician rather than simply eliminating large groups of foods.
What About Alcohol and Caffeine?
Neither topic needs an extreme answer for every patient.
Alcohol can worsen dehydration and may trigger palpitations or atrial fibrillation in susceptible people.
If drinking reliably makes symptoms worse, reducing or avoiding alcohol is sensible.
For broader evidence, see Alcohol and Heart Health.
Caffeine tolerance varies.
Large doses, energy drinks, and stimulant containing pre workout products deserve particular caution if they cause rapid heart rate or palpitations.
Bring supplements and stimulant products to your cardiology appointment rather than assuming that “natural” means safe for HCM.
When Should You Call Your HCM Team?
Contact the clinician managing your HCM when you develop a meaningful change such as:
- More breathlessness than usual
- New chest discomfort
- More frequent palpitations
- New dizziness
- Near fainting
- A clear drop in exercise ability
- New swelling
- A wearable alert showing a persistent abnormal rhythm
Fainting during activity deserves particular attention because the HCM sudden death risk assessment specifically considers recent fainting suspected to be caused by an arrhythmia.
When Is Hypertrophic Cardiomyopathy an Emergency?
Seek emergency medical care for:
- Fainting during exercise or significant exertion
- Severe or persistent chest pain or pressure
- Severe shortness of breath at rest
- Collapse or loss of consciousness
- A sustained rapid heartbeat with faintness or serious breathlessness
- Symptoms suggesting cardiac arrest
Do not try to treat severe symptoms only by drinking water, lying down, or changing heart medicine without emergency medical guidance.
10 Questions Worth Asking Your Cardiologist
- Is my HCM obstructive or nonobstructive?
- What is my maximum heart wall thickness?
- Do I have an outflow tract gradient at rest or during exercise?
- What did my cardiac MRI show about scar?
- What is my current, sudden cardiac death risk profile?
- Do I need longer rhythm monitoring?
- What type and intensity of exercise are appropriate for me?
- Could a cardiac myosin inhibitor be appropriate for my obstructive HCM?
- Should my children, siblings, or parents have genetic or clinical screening?
- Which symptoms mean I should contact you, and which require emergency care?
Seven HCM Mistakes to Avoid
1. Avoiding All Exercise
Modern guidance supports mild to moderate recreational exercise for most patients.
2. Assuming Every Thick Heart Is Genetic HCM
High blood pressure, valve disease, athletic remodeling, amyloidosis, and other conditions can mimic HCM.
3. Ignoring Dehydration
Low blood volume can worsen obstruction in susceptible patients.
4. Using Someone Else's Exercise Restrictions
Risk varies widely between patients.
5. Forgetting Family Screening
HCM can be inherited, and relatives may have no symptoms.
6. Treating an ICD as a Universal Requirement
ICDs are lifesaving for selected high risk patients but expose low risk patients to unnecessary device risks.
7. Thinking HCM Treatment Has Not Changed
Cardiac myosin inhibitors and modern shared decision making have changed management substantially.
Conclusion
Hypertrophic cardiomyopathy does not require a life built around fear and inactivity.
Modern care is built around knowing your individual HCM pattern, staying active at a safe level, avoiding dehydration, controlling other cardiovascular risks, monitoring symptoms and rhythm, assessing sudden death risk, screening family members, and using increasingly targeted treatments when symptoms need more help.
The treatment options continue to move quickly. Mavacamten changed obstructive HCM care, aficamten became FDA approved in December 2025, and 2026 research is already exploring myosin inhibition more deeply in nonobstructive disease.
Your next step: at your next cardiology visit, ask whether your HCM is obstructive, when your sudden death risk was last reviewed, what activity level is safe for you, and whether your first degree relatives need screening.
References and Sources
- American College of Cardiology and American Heart Association.
2024 Guideline for the Management of Hypertrophic Cardiomyopathy. Covers diagnosis, echocardiography, cardiac MRI, family screening, sudden cardiac death risk, exercise, medication, septal reduction treatment, atrial fibrillation, and pregnancy.Source:
https://www.jacc.org/doi/10.1016/j.jacc.2024.02.014
- American Heart Association.
Key Patient Messages From the 2024 Hypertrophic Cardiomyopathy Guideline. Explains shared decision making, HCM centers, exercise, genetic screening, and cardiac myosin inhibitors in patient friendly language.Source:
https://professional.heart.org/en/science-news/patient-resources/key-patient-messages-hypertrophic-cardiomyopathy-2024-clinical-practice-guideline
- U.S. Food and Drug Administration.
FDA Approval of Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy. Approval date December 19, 2025. Covers indication, trial evidence, heart failure risk, echocardiographic monitoring, and REMS requirements.Source:
https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-drug-improve-functional-capacity-and-symptoms-adults-rare-inherited-heart-condition
- American College of Cardiology.
ACACIA HCM Trial Report, August 2026. Covers the latest phase 3 evidence for aficamten in symptomatic nonobstructive HCM while noting that this remains separate from the currently approved obstructive HCM indication.Source:
https://www.acc.org/latest-in-cardiology/articles/2026/08/24/12/30/fri-545am-acacia-hcm-esc-2026
- Mayo Clinic.
Hypertrophic Cardiomyopathy Diagnosis and Treatment. Covers echocardiography, ECG, rhythm monitoring, cardiac MRI, exercise testing, medicines, procedures, exercise, diet, smoking, weight, and alcohol.Source:
https://www.mayoclinic.org/diseases-conditions/hypertrophic-cardiomyopathy/diagnosis-treatment/drc-20350204
Continue Reading on NextFitLife
- Heart and Cardiovascular Health Guide
for heart disease, cardiomyopathy, blood pressure, cholesterol, circulation, symptoms, and cardiovascular prevention - Heart Health 101
for cardiovascular basics, blood pressure, cholesterol, blood sugar, exercise, sleep, screening, and prevention - Heart Failure Symptoms
for breathlessness, swelling, fatigue, rhythm changes, heart imaging, modern treatment, and emergency warning signs - Sleep and Heart Health
for sleep apnea, atrial fibrillation, blood pressure, sleep quality, and cardiovascular risk - How to Lower Blood Pressure Safely
for home measurement, lifestyle changes, hypertension treatment, and cardiovascular protection - Exercises for Cholesterol and Heart Health
for aerobic activity, resistance exercise, fitness, and heart healthy movement - Alcohol and Heart Health
for atrial fibrillation, blood pressure, sleep, alcohol exposure, and cardiovascular risk - Medical Tests and Screenings Guide
for understanding ECGs, heart imaging, blood testing, screening, and questions to ask before and after medical tests
About the Author
Adel Galal is the founder and lead writer of NextFitLife. His personal interest in health, fitness, nutrition, cardiovascular wellness, sleep, and healthy aging spans more than 30 years, and his health and wellness writing experience spans more than 15 years.
Before focusing on NextFitLife, Adel spent 29 years working as an IT Manager for the Nestlé Egypt Region. His professional background includes information systems, data analysis, structured research, planning, problem solving, and information management.
He applies those research skills to consumer health writing by comparing medical guidelines, tracking treatment updates, separating general heart healthy habits from HCM specific safety issues, and explaining technical topics such as outflow obstruction, genetic screening, sudden cardiac death risk, cardiac MRI, and myosin inhibitor therapy in plain language.
For this update, Adel reviewed the 2024 AHA and ACC HCM guideline, current American Heart Association patient guidance, FDA information on aficamten and mavacamten, the latest 2026 ACACIA HCM results, and Mayo Clinic HCM guidance.
Adel is not a physician, cardiologist, electrophysiologist, genetic counselor, pharmacist, registered nurse, sports medicine physician, or other licensed healthcare professional. NextFitLife provides general educational information and does not replace HCM diagnosis, genetic counseling, rhythm monitoring, exercise clearance, prescription treatment, ICD decisions, or individualized cardiology care.
Learn more about Adel Galal, NextFitLife, sourcing standards, corrections, and the site's editorial approach on the About Us page.
Frequently Asked Questions About Hypertrophic Cardiomyopathy
What is hypertrophic cardiomyopathy?
Hypertrophic cardiomyopathy is a heart muscle disease in which part of the heart becomes abnormally thick. It is commonly inherited and can affect heart filling, blood flow, heart rhythm, and exercise ability.
What is the difference between obstructive and nonobstructive HCM?
Obstructive HCM creates significant resistance to blood leaving the left ventricle. Nonobstructive HCM has abnormal muscle thickening without the same level of outflow blockage.
What are common HCM symptoms?
Symptoms can include shortness of breath, chest discomfort, fatigue, palpitations, dizziness, fainting, and reduced exercise ability. Some people have no symptoms.
Can you exercise with hypertrophic cardiomyopathy?
Yes. Current guidelines recommend mild to moderate recreational activity for most patients. Vigorous activity and competitive sport need individualized assessment and shared decision making with an HCM specialist.
Is vigorous exercise always banned in HCM?
No. Universal restriction from vigorous recreational activity or competitive sport is no longer recommended for every patient. Individual risk assessment is still essential.
Why is dehydration important in HCM?
Dehydration lowers circulating blood volume and can worsen left ventricular outflow obstruction in some people, especially those with obstructive HCM.
Is there a special diet for hypertrophic cardiomyopathy?
No specific diet reverses HCM. A heart healthy eating pattern can help manage body weight, blood pressure, cholesterol, diabetes, and overall cardiovascular risk.
Is hypertrophic cardiomyopathy genetic?
HCM is commonly genetic and can run through families. Genetic counseling and testing can help identify a disease causing variant in some families.
Should family members be screened for HCM?
Yes. Current guidelines recommend clinical screening of first degree relatives with an ECG and echocardiogram and cascade genetic testing when a pathogenic family variant is known.
How often should adults in an HCM family be screened?
At risk adults are commonly screened every three to five years when they remain phenotype negative, although symptoms and family history can justify earlier testing.
How often should children in an HCM family be screened?
Children from genotype positive or early onset families may need screening every one to two years. Other children may commonly be screened every two to three years. The schedule should be individualized.
What medicine is used for obstructive HCM?
Beta blockers are commonly first line treatment for symptomatic obstructive HCM. Verapamil or diltiazem can be alternatives in suitable patients. Persistent symptoms can lead to consideration of a cardiac myosin inhibitor, disopyramide, or septal reduction treatment.
What is mavacamten?
Mavacamten is a cardiac myosin inhibitor approved for selected adults with symptomatic obstructive HCM. It reduces excessive heart muscle contraction and requires careful cardiac monitoring.
What is aficamten?
Aficamten is a cardiac myosin inhibitor that received FDA approval in December 2025 for adults with symptomatic obstructive HCM to improve functional capacity and symptoms.
Is aficamten approved for nonobstructive HCM?
As of September 2026, no. A 2026 phase 3 trial reported benefits in symptomatic nonobstructive HCM, but positive research results are not the same as an approved indication.
What is septal myectomy?
Septal myectomy is heart surgery that removes part of the thickened septum to reduce obstruction. It is performed for selected patients with significant symptomatic obstructive HCM, ideally at an experienced HCM center.
What is alcohol septal ablation?
Alcohol septal ablation uses a controlled amount of alcohol delivered through a small coronary artery to reduce part of the thickened septal muscle. It is an option for selected patients when appropriate.
Does everyone with HCM need an ICD?
No. ICD treatment is based on individual sudden cardiac death risk. It is clearly recommended after cardiac arrest or sustained ventricular arrhythmia and considered for selected high risk patients.
Can women with HCM become pregnant?
Many clinically stable women with HCM can have successful pregnancies, but pregnancy should be planned with cardiology and obstetric care. Some HCM medicines are unsafe during pregnancy.
When is hypertrophic cardiomyopathy an emergency?
Seek emergency care for exertional fainting, severe chest pain, severe shortness of breath, collapse, loss of consciousness, or a sustained rapid heartbeat with serious symptoms.
Health & wellness writer with 30+ years of experience in nutrition, fitness, and healthy aging. Founder of NextFitLife.com — evidence-based health guidance.
